The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Atul Pathak
Showing 1-9 of 9 articles
Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Barbato E,
Azizi M,
Schmieder RE,
Lauder L,
Böhm M,
Brouwers S,
Bruno RM,
Dudek D,
Kahan T,
Kandzari D,
Lüscher T,
Parati G,
Pathak A,
Ribichini F,
Schlaich M,
Sharp A,
Sudano I,
Volpe M,
Tsioufis C,
Wijns W,
Mahfoud F
March 20, 2023 | 10.4244/EIJ-D-22-00723
Will SPYRAL HTN-ON MED change my practice? SPYRAL HTN-ON MED: a prospective, randomised, sham-controlled trial on renal denervation in the presence of antihypertensive medications
Ewen S,
Lauder L,
Azizi M,
Kandzari D,
Pathak A,
Sharif F,
Wijns W,
Mahfoud F,
Lüscher T
August 3, 2018 | 10.4244/EIJY18M07_1
FOURIER to ODYSSEY: the end of the journey for lipid-lowering therapy trials? Lessons from recent clinical trials with anti-PCSK9 antibodies
Sabouret P,
Angoulvant D,
Pathak A
June 20, 2018 | 10.4244/EIJY18M04_1
Chemical sympathetic denervation: promising, but important distinctions between agents and methods
Bertog S,
Vega F,
Ghazarossian V,
Pathak A,
Vaskelyte L,
Sievert H,
Ladich E,
Yahagi K,
Virmani R
October 11, 2017 | 10.4244/EIJ-D-16-01000R
Randomised, blinded and controlled comparative study of chemical and radiofrequency-based renal denervation in a porcine model
Bertog S,
Fischell T,
Vega F,
Ghazarossian V,
Pathak A,
Vaskelyte L,
Kent D,
Sievert H,
Ladich E,
Yahagi K,
Virmani R
February 3, 2017 | 10.4244/EIJ-D-16-00206
Will SPRINT change my practice? SPRINT: a randomised trial of intensive versus standard blood-pressure control
Ewen S,
Lobo M,
Pathak A,
Schmieder RE,
Tsioufis C,
Wijns W,
Mahfoud F
August 20, 2016 | 10.4244/EIJV12I6A132
Renal sympathetic nerve denervation using intraluminal ultrasound within a cooling balloon preserves the arterial wall and reduces sympathetic nerve activity
Pathak A,
Coleman L,
Roth A,
Stanley J,
Bailey L,
Markham P,
Ewen S,
Morel C,
Despas F,
Honton B,
Senard J,
Fajadet J,
Mahfoud F
August 20, 2015 | 10.4244/EIJV11I4A96
From SYMPLICITY HTN-3 to the Renal Denervation Global Registry: where do we stand and where should we go?
Pathak A,
Ewen S,
Fajadet J,
Honton B,
Mahfoud F,
Marco J,
Schlaich M,
Schmieder RE,
Tsioufis C,
Ukena C,
Zeller T
May 20, 2014 | 10.4244/EIJV10I1A4
First report of transradial renal denervation with the dedicated radiofrequency Iberis™ catheter
Honton B,
Pathak A,
Sauguet A,
Fajadet J
April 22, 2014 | 10.4244/EIJV9I12A235
1
Latest news
AHEAD OF PRINT
Two-year outcomes after TMVR
FREE ARTICLE - Sebastian Ludwig et al
May 26, 2023
Simultaneous Publications at EuroPCR 2023!
May 12, 2023
NEW ISSUE
Debating Invasive Coronary Testing in INOCA Patients; Single Antiplatelet Therapy After PCI; Ultrasound-Guided Femoral Access in the UNIVERSAL Trial
May 12, 2023
AHEAD OF PRINT
BIOSOLVE-IV registry
FREE ARTICLE - Adrian Wlodarczak et al
May 24, 2023
AHEAD OF PRINT EUROPCR
The EURO SHOCK Trial
FREE ARTICLE - Amerjeet Singh Banning et al
May 19, 2023
AHEAD OF PRINT EUROPCR
Early safety and feasibility of a first-in-class biomimetic transcatheter aortic valve (DurAVR)
FREE ARTICLE - Susheel K. Kodali et al
May 19, 2023
AHEAD OF PRINT EUROPCR
TAVI for bicuspid aortic valves with Evolut platform
FREE ARTICLE - Didier Tchétché et al
May 18, 2023
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke